Daniel Janse

Daniel Janse

Verkställande Direktör på
Affyimmune Therapeutics, Inc.
Health Technology
Consumer Services
Commercial Services

Profil

Daniel Janse is currently the President & Chief Executive Officer at Affyimmune Therapeutics, Inc. He previously held positions as the Director at Cell Therapy Ltd. in 2011, Senior Director at Juno Therapeutics GmbH from 2016 to 2018, Managing Director at Northpond Ventures LLC in 2023, Senior Director at Johnson & Johnson Innovation from 2013 to 2016, Manager at McKinsey & Co., Inc. from 2008 to 2011, Investment Manager at Inventages Venture Capital Investment, Inc. from 2011 to 2013, and Chief Operating Officer at Arbor Biotechnologies, Inc. from 2020 to 2021.
Dr. Janse obtained his undergraduate degree from Brown University in 1998 and his doctorate degree from Harvard University in 2005.

Aktiva positioner av Daniel Janse

FöretagPositionStart
Verkställande Direktör 2024-07-15

Tidigare kända positioner av Daniel Janse

FöretagPositionSlut
Direktör/Styrelseledamot 2023-01-01
Verksamhetschef 2021-05-31
Privat kapitalinvesterare 2018-07-31
Privat kapitalinvesterare 2016-09-30
Företagsledare/Principal 2013-07-31
Se detaljerna i Daniel Janses erfarenhet

Daniel Janses utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

94

Första gradens relationer

10

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag10

Consumer Services

Commercial Services

Consumer Services

Finance

Health Technology

Health Services

Health Technology

Health Technology

Finance

Commercial Services

  1. Börsen
  2. Insiders
  3. Daniel Janse